Skip to content

Evaluation the efect preemptive administration cheledaghi extract on post operative pain in elective hysterectomy sections

Evaluation the effect of preemptive administration cheledaghi extract on post operative pain in elective hysterectomy sections

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201201115567N2
Enrollment
90
Registered
2012-03-04
Start date
2011-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after hysterectomy. Complication of labour and delivery, unspecified

Interventions

Intervention 1: In first intenventional group supp placebo 24 h before surgery every 12 hours and 24h after surgery the supp of eremostachyc laciniata every 12h is adminesteration and the severity of
Treatment - Drugs
In first intenventional group supp placebo 24 h before surgery every 12 hours and 24h after surgery the supp of eremostachyc laciniata every 12h is adminesteration and the severity of pain with VAS a
In second inventional group supp eremostachys laciniata is adminestered 24h before to 24h after surgery every 12h and the severity of pain with VAS and need to analgesia was determind.
In control group adminestration suup placebo 24h before to 24h after surgery every 12h and severity of pain with VAS and need to analgesia is analysed.

Sponsors

Womens Reproductive Health Research Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients aged between 20 to 50 years who are candidate for elective hysterectomy. Exclusion criteria are: 1)age lower than 35 years 2)history of sever diseases and 3)duration of operation longer than 120 miniuts.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain after hysterectomy section. Timepoint: 24 hourse aftere surgery. Method of measurement: Visual Analogous Scale(VAS).

Secondary

MeasureTime frame
Need to analgesics. Timepoint: After surgery. Method of measurement: Patients' medical records.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPoone Zamani

Tabriz University of Medical Sciences

www.poone zamani@yahoo.com

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026